Casey Means on Weight-Loss Drugs as a First-Line Answer: warns against

Dr. Casey Means warns against relying on weight-loss drugs such as GLP-1 medications (Ozempic) as a first-line answer to metabolic dysfunction. In the “Beyond Ozempic” episode of the Liz Moody podcast, Means emphasizes holistic lifestyle and metabolic interventions over reliance on the drugs, and raises the Ozempic-for-kids debate as controversial.

Means’s stated reasoning is that metabolic dysfunction has root causes — food, movement, sleep, stress, environmental inputs — that drugs manage rather than resolve, and that defaulting to pharmaceuticals, especially for children, skips the root-cause work her framework prioritizes. The episode title itself frames her alternative: a lifestyle-based metabolic plan rather than a prescription-first approach.

What Means says

• Means emphasizes holistic lifestyle and metabolic interventions over reliance on GLP-1 medications like Ozempic.
• Means raises Ozempic-for-kids as a controversial proposition.

All claims above are attributed to Means, drawn from her Liz Moody “Beyond Ozempic” appearance; they are presented as her stated position, not established medical fact. This site does not offer medical advice on prescription drugs.

This page chronicles a stated position of the person above. It is not medical advice and not the site's own conclusion.